Logo

PD-L1 Biomarkers

News and reporting on PD-L1 biomarkers.

EU IVDR Implementation Woes Could Severely Limit Cancer Companion Test, Precision Therapy Access
Premium

The EC has stuck with its timeline to implement the new regulations in eight months, raising concerns for cancer patients' ability to receive biomarker testing and treatments.

Labcorp, CCORN Ink Partnership to Address Precision Oncology Disparities

The Community Clinical Oncology Research Network will leverage Labcorp's comprehensive genomic profiling test to build out a registry of diverse patient data. 

Astronomy, Biology Come Together for Cancer Biomarker Discovery
Premium

Johns Hopkins researchers have developed a single-cell, multispectral imaging platform called AstroPath for precise pathological analysis of cancer specimens.

Breast Cancer Immunotherapy Response Markers Emerge From Single-Cell Sequencing Study

Researchers identified several pre-treatment markers that correlated with T-cell expansion and could be predictive of response to a PD1 inhibitor.

NanoView, Beth Israel Deaconess Medical Center Launch Immuno-Oncology Biomarker Study

The team will use NanoView's ExoView platform to characterize PD-L1 and other biomarkers carried by exosomes in plasma samples from patients undergoing therapy.

Dec 2, 2020

Diaceutics, Alva10 Gathering Evidence Base for Improving PD-L1 Test Reimbursement
Premium

Nov 13, 2020

FDA Approves Merck's Keytruda, Agilent CDx in PD-L1-High Triple-Negative Breast Cancer

Aug 10, 2020

T Cell Receptor Repertoire Linked to Anti-PD-1 Therapy Response in Hodgkin Lymphoma

Apr 30, 2020

Washington University, BostonGene Expand Kidney Cancer Research Collaboration

Nov 6, 2019

Merck, Promega Collaborate to Develop MSI CDx for Keytruda

Aug 5, 2019

IncellDx Inks Chinese Collaboration, Distribution Agreements

Jun 1, 2019

ASCO Studies Show Keytruda Increases Five Year Survival in NSCLC, Provides New Gastric Cancer Option
Premium

May 2, 2019

Arcus Biosciences, Strata Oncology Team Up to Advance Anti-PD-1 Drug

Apr 10, 2019

Foundation Medicine, Flatiron Health Publish Clinical Validity of Clinico-Genomics Database

Apr 9, 2019

Immunotherapy Developers, Clinical Researchers Continue to Seek New Dx Strategies
Premium

Jan 15, 2019

Tumor Mutation Burden Predicts Immunotherapy Benefit Across Cancers, Though Cutoffs Differ
Premium

Dec 5, 2018

Genentech Data Shows Breast Cancer Patient Subgroups May Benefit from Its Drugs
Premium

Aug 21, 2018

FDA Approves Expanded Use of Agilent Assay as Keytruda CDx for Urothelial Cancer

Jun 15, 2018

PDL1 Amplifications Mark Subset of Solid Tumors, May Point to Checkpoint Blockade Response

Jun 5, 2018

WIN Consortium Applies Transcriptomics to Bolster Patient Matching in Precision Oncology Study
Premium

Apr 17, 2018

At AACR, Immuno-Oncology Clinical Trials Offer Mixed Messages on Predictive Biomarkers
Premium

Sep 22, 2017

FDA Approves Merck's Keytruda, Agilent Dako CDx for Gastric Cancer Indications

Aug 15, 2017

ASCO Updates NSCLC Guidelines With New Directives for Genomic Testing

May 11, 2017

Which PD-L1 Assay to Use With Which NSCLC Immunotherapy? There's an Atlas for That Now
Premium

May 2, 2017

FDA Approves Roche's PD-L1 Test for Bladder Cancer

Breaking News
The Scan

Looking for Omicron

NPR reports that SARS-CoV-2 testing in the US has gotten better but also that some experts say more needs to be done to better track the Omicron variant.

Holmes Alleges Abuse

The Associated Press reports that Theranos' Elizabeth Holmes has testified at her wire fraud trial that her business and romantic partner abused her.

Bit More Diverse, But More to Do

While Black and Hispanic patients are more likely to participate in cancer clinical trials than previously, they are still underrepresented, according to US News & World Report.

PNAS Papers on Yeast Gene Silencing, Zika Virus Inhibition, Immunoglobulin Hypermutation

In PNAS this week: gene silencing in Saccharomyces cerevisiae, possible neuroprotective role for SHFL in a mouse model of Zika virus infection, and more.